Conrad Kunick

Early process development of API applied to poorly water‐soluble TBID

Stephan Scholl, Martin Schoenitz, Marius Meise, 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Parenteral formulation of an antileishmanial drug candidate--tackling poor solubility, chemical instability, and polymorphism.

Heike Bunjes, Conrad Kunick, C. Kunick, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

1‐Azakenpaullone Is a Selective Inhibitor of Glycogen Synthase Kinase‐3β.

Laurent Meijer, Conrad Kunick, L. Meijer, 2004 .

Alsterpaullone, a novel cyclin‐dependent kinase inhibitor, induces apoptosis by activation of caspase‐9 due to perturbation in mitochondrial membrane potential

Conrad Kunick, A. De Siervi, C. Kunick, 2003, Molecular carcinogenesis.

Selective inhibitors of Plasmodium falciparum glycogen synthase-3 (PfGSK-3): New antimalarial agents?

Conrad Kunick, C. Kunick, Andreas Masch, 2015, Biochimica et biophysica acta.

Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4

Peter G Schultz, Rudolf Jaenisch, Conrad Kunick, 2009, Proceedings of the National Academy of Sciences.

Plasmodium falciparum glycogen synthase kinase-3: molecular model, expression, intracellular localisation and selective inhibitors.

Laurent Meijer, Virginie Thomas, Conrad Kunick, 2004, Biochimica et biophysica acta.

Structure‐Aided Optimization of Kinase Inhibitors Derived from Alsterpaullone

Rick Gussio, Laurent Meijer, Conrad Kunick, 2005, Chembiochem : a European journal of chemical biology.